Dr. John C. Hwang, MD

Dr. Hwang practices at Saddleback Pain and Surgical Center in Laguna Hills, California.

Dr. Hwang's NPI, 1629235510, was assigned on May 19, 2008. Dr. Hwang graduated from Vagelos College of Physicians and Surgeons in 2005. Dr. Hwang holds California license A112582.

Dr. Hwang's primary practice is Saddleback Pain and Surgical Center, at 23521 Paseo De Valencia, Suite 204, Laguna Hills, CA 92653. The practice phone is (949) 458-2026.

Dr. Hwang's primary practice is Saddleback Pain and Surgical Center in Laguna Hills, California. Dr. Hwang is also affiliated with Englewood Hospital. Dmand AI also links Dr. Hwang to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hwang practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Hwang's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Hwang is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Hwang's licenses on file in 2 states: California and New York.

Dmand AI lists age-related macular degeneration, cataract, dry eye, eyelid inflammation, glaucoma, hypertensive retinopathy, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Hwang treats.

CMS data shows 29,598 Medicare services from Dr. Hwang across 16 procedure codes in 2024, for 886 Medicare patients. Medicare paid $1,989,344 for them. Every service was in an office.

CMS counts 886 Medicare patients who saw Dr. Hwang in 2024. The largest group is 65 to 74, with 338 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hwang's median patient age at 74, with 54% women.

In 2024, Dr. Hwang wrote 514 Medicare Part D claims for 129 patients. 52% of them were for generic drugs. CMS names the drug for 485 of them, across 7 drugs with 11 or more claims each, at $12,321 in total drug cost. In 2023, CMS named 452 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hwang for performance year 2024, reported as part of a group. Dr. Hwang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Dr. Hwang, published from 2006 to 2024. 2010 was the busiest year, with 3. The most frequent topics are Visual Acuity, Fluorescein Angiography and Tomography, Optical Coherence. Dr. Hwang has published most often in Retina. Dr. Hwang's most frequent co-authors are Stanley Chang, MD, Royce Welford Shen Chen, MD and Michael F. Chiang, MD.

CMS Open Payments shows 54 general payments to Dr. Hwang from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Alcon Research Ltd paid the most, $3,217.

Dr. Hwang graduated from Vagelos College of Physicians and Surgeons in 2005.

Dr. Hwang is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.